How much funding has Genentech raised?

Genentech has raised $492.3M in total funding, most recently a Corporate Round.

Who are Genentech's investors?

Genentech's investors include Kleiner Perkins, Roche, Hambrecht & Quist, Mayfield Fund.

Where is Genentech headquartered?

Genentech is headquartered in San Francisco, California, United States.

What industry is Genentech in?

Genentech operates in Biotech, Drug Discovery, Therapeutics.

How many employees does Genentech have?

Genentech has 10001+ employees.

Genentech

IPO

Pioneering the biotechnology industry to deliver life-changing medicines

Public · San Francisco, United States · Founded 1976 · $492.3M raised

Biotech

Drug Discovery

Therapeutics

Headquarters: San Francisco, California
Employees: 10001+
Founded: 1976
Business Model: B2B
Website: gene.com

Total Funding: $492.3M
Last Round: $492.0M Corporate RoundFeb 1990
Rounds: 2
Type: Public

About

Genentech, a member of the Roche Group and pioneer of biotechnology, discovers and develops breakthrough medicines for serious diseases including cancer, neurological disorders, and ophthalmological conditions. Founded in 1976 as the world's first biotech company, it has delivered over 30 FDA-approved therapies. The company integrates AI end-to-end across its R&D ecosystem to accelerate drug discovery, clinical trials, and manufacturing.

Summary

Genentech is a Biotech company based in San Francisco, United States, founded in 1976. It has raised $492.3M in total across 2 rounds, most recently a $492.0M Corporate Round round in Feb 1990. Investors include Kleiner Perkins, Roche and Hambrecht & Quist.

LinkedIn X (Twitter)